H. C. Fehmann

2.5k citations
47 papers · 2.0k · 1 hit paper · h-index 18

Impact in

Papers in

H. C. Fehmann

42 papers receiving 1.9k citations

H. C. Fehmann's Hit Papers

Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. 1993 · 696 citations
6960+11+22Years since publication200400600

Peers

H. C. Fehmann
Comparison fields: 5 of 81
  • Endocrinology, Diabetes and Metabolism 1.2k
  • Endocrine and Autonomic Systems 272
  • Cellular and Molecular Neuroscience 425
  • Surgery 924
  • Physiology 224
Replace Carolyn M. Jodka with:
Carolyn M. Jodka United States
Bo Ahrén Sweden
A. Kervran France
R H Unger United States
Richard Pittner United States
Sunil Bhavsar United States
Alexander M. Efanov Sweden
Susanne G. Straub United States
Peter Thams Denmark
W. S. Zawalich United States
H. C. Fehmann relative to Carolyn M. Jodka United States Carolyn M. Jodka's profile →
Citations per field
00.5×1.5×1.8×
Carolyn M. Jodka · 1×
Citations per year

Countries citing papers authored by H. C. Fehmann

Since Specialization
Citations

This map shows the geographic impact of H. C. Fehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. C. Fehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. C. Fehmann more than expected).

Fields of papers citing papers by H. C. Fehmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. C. Fehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. C. Fehmann. The network helps show where H. C. Fehmann may publish in the future.

Co-authors

The 25 scholars most cited alongside H. C. Fehmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with H. C. Fehmann Line = papers co-authored together H. C. Fehmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
Hit paper breakdown →
1993696
2 1992271
3 199181
4 200279
5 199078
6 199170
7 199466
8 199264
9 199153
10 199749
11 198945
12 199545
13 198944
14 199440
15 199034
16 199733
17 199728
18 199225
19 199517
20 199417

About H. C. Fehmann

H. C. Fehmann is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Cellular and Molecular Neuroscience and Epidemiology, having authored 47 papers that have together received 2.0k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (28 papers), Pancreatic function and diabetes (23 papers), Neuropeptides and Animal Physiology (16 papers), Receptor Mechanisms and Signaling (11 papers), Neuroendocrine Tumor Research Advances (8 papers), Diabetes Management and Research (6 papers), Metabolism, Diabetes, and Cancer (4 papers) and Regulation of Appetite and Obesity (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.2k citations), Endocrine and Autonomic Systems (272 citations), Cellular and Molecular Neuroscience (425 citations), Surgery (924 citations) and Physiology (224 citations). H. C. Fehmann has collaborated with scholars based in Germany, United States and Estonia. Frequent co-authors include Burkhard Göke, Joel F. Habener, Rüdiger Göke, Michael Krause, Thomas Linn, John Eng, Harald Schmidt, R. Arnold, Jens Heyn and P. Berghöfer. Their work appears in journals such as Experimental and Clinical Endocrinology & Diabetes, Endocrinology, Neuropeptides, FEBS Letters and European Journal of Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact